Related Experiment Video
Updated: May 31, 2026

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
Published on: August 21, 2016
Genomic databases access agreements: legal validity and possible sanctions.
Yann Joly1, Nik Zeps, Bartha M Knoppers
1Deptartment of Human Genetics, Faculty of Medicine, Centre of Genomics and Policy, McGill University, 740 Dr. Penfield Avenue, Suite 5101, Montreal, QC H3A 1A4, Canada. yann.joly@mail.mcgill.ca
This study reviews sanctions for misuse of public genomic data. Clear, predictable data access agreements are crucial for researchers and stakeholders to ensure responsible data use.
Area of Science:
- Genomic Data Management
- Bioethics and Data Governance
- Scientific Research Compliance
Background:
- Public genomic databases have accelerated research capabilities.
- Data access agreements (DAAs) are vital for responsible data sharing.
- Sanctions for data misuse are a critical but under-researched component of DAAs.
Purpose of the Study:
- To review potential sanctions for non-compliance with genomic data access agreements.
- To highlight the importance of standardization and transparency in DAAs.
- To identify the need for further empirical research on DAA clarity and accessibility.
Main Methods:
- Comprehensive literature review and analysis of over 450 documents.
- Examination of journal articles, policies, guidelines, and access policies.
- Identification and categorization of potential sanctions for data misuse.
Main Results:
- A range of sanctions for non-compliance with genomic data access agreements were identified.
- Even mild sanctions can have significant impacts on data users.
- Existing DAAs and related policies may lack clarity and predictability.
Conclusions:
- Standardization and transparency in designing controlled-access agreements are essential.
- Clear delineation of acceptable and unacceptable conduct is necessary for users.
- Further empirical studies are needed to assess the clarity and accessibility of current DAAs.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
Related Concept Videos
Legal Guidelines for Documentation
Genomics
Genomic DNA in Eukaryotes
DNA Microarrays
What is Genetic Engineering?
Genome Annotation and Assembly